Archive for the ‘Virus protection’ Category
See Swine Flu safety info. See data illustrated.
Journalist David McCandless, a London-based author, writer and designer, has a superior summary of everything which a Swine Flu vaccine can do, based on a wide variety of public sources. Best of all, it’s presented in illustrated format.
One major surprise to me is the amount of mercury (thimerosal) that’s inserted into flu shots. A can of tuna has about twice as much mercury as any thimerosal you will find in an injection. The nasal application of the H1N1 vaccine contains zero micrograms of mercury. But getting vaccinated with an inhaled formula isn’t recommended for anyone over 50. This is the same age group that has only a 4 percent chance of contracting this kind of influenza. The data so far also indicates that this flu is being contracted mostly by people under 25. He also concludes that the chances of dying of the current vaccine are more than 1 in a million.
McCandless’s Swine Flu data is at informationisbeautiful.net, along with dozens of other interesting presentations.
WHO reports: Swine vaccine now in 65 million bodies
The World Health organization has surveyed 16 countries and believes that 65 million vaccinations for swine flu have taken place worldwide. Perceived risks of vaccination include Guillain-Barre syndrome, and the WHO report says “fewer than 10 cases of Guillain-Barre syndrome have been reported” among people who received vaccines.
24 more countries are among those surveyed by the WHO, but the results in this majority of the world aren’t part of the report. Despite the safety reports, a new CNN poll asserts that the majority of Americans don’t want to receive an H1N1 vaccination.
According to the poll, 55 percent of adults don’t want to get the swine flu vaccine and don’t plan to get a shot. Another one in five say they want to get inoculated but haven’t taken any steps to do so; 14 percent want a shot and have tried to get it but have been unsuccessful. Just 7 percent have been inoculated for H1N1.
A “small number” of deaths have been reported to the World Health Organization, but given its optimism for the vaccine, the WHO believes its investigations can’t find a link between vaccine and death. “The results of completed investigations reported to WHO have ruled out a direct link to pandemic vaccine as the cause of death.”
But the CNN poll lists concern over side effects as the top reason more than half of the US residents surveyed don’t want a vaccine. The poll director calculates that 28 percent of the adult population don’t plan to get inoculated due to the risk of dangerous side effects.
More social distancing from flu
The Infoworld enterprise computer newspaper reports that working outside the office is a new employment perk.
The H1N1 pandemic is pushing companies to upgrade their secure remote access capabilities in order to enable more employees to work out of their homes and other remote locations in an emergency.
Vendors of remote access technologies are reporting an unexpected increase in demand for their products over the past several months as a result of H1N1-related concerns.
Being honest, the lack of contact with other humans and their coughing is one sure way to reduce chances of infection. It will, however, lead to severe withdrawal from the physical pleasures we enjoy in life. And so, the need for SimSuits is born in Viral Times.
Glaxo Smith-Kline goes behind the viral mask
The British pharma giant GlaxoSmithKline has created an anti-virus face mask, new to the world markets this year. The FDA approved the masks, called ActiProtect, for sale to US health care workers as an “occupational use” product. GSK claims in its testing that ActiProtect kills 99.99 of viruses that make contact with the mask, dead within one minute. GSK uses the term “inactivated” for the virus particles. By most measures, viruses are not alive until they latch onto a host’s tissue.
Although H1N1 is among the viruses listed that ActiProtect’s coating kills, the 2009 strain hasn’t been included among those vulnerable to the mask. ActiProtect doesn’t include a drug in its manufacture, simply an antiviral inactivation coating on the surface of the FFP2 mask. The mask is a coated version of a protection mask that’s been in use in industry for years. GSK has a patent pending on ViruCoat, which covers the outer surface of the mask.
You can’t buy one of these unless you’re in the healthcare business today. GSK would like to change that to expand its sales, but the US FDA ruling stands in the way. You wouldn’t consider the masks attractive, but they might be effective. Or not, depending on how many flu viruses particles are in the air. Fashion? You may have wait awhile. In the world of Viral Times, the society wears SafeMasks designed by Hugo Boss and Cole Haan.
For a 2009 modeling session, you can watch an entertaining YouTube video of the ActiProtect masks. Somehow, a British voice doing the explanation and narration makes it all seem less dire.
Natural remedies to outlast pharma cures
My wife and I get our primary care from Central Family Practice here in Austin. It’s a remarkable medical group because it gives equal emphasis to Western and traditional medicine. They’re just as likely to give you Chinese herbs as a prescription to fill. Whatever remedy works best, they’ll offer it.
Tamiflu is not big on their list, and with good reason. It’s an all-purpose drug aimed (poorly) at specific viruses. Instead, they advise you use something natural. Viruses can be reined in better with natural remedies than with pharma cures — the natural medicine doesn’t spark a virus to mutate like a pharma drug does.
Central Family Practice sent this Facebook message tonight:
Oscillococcinum, the remedy you don’t have to be able to pronounce for it to work. Oscillococcinum is a natural flu remedy. CFP has it in stock.
If you’re in Austin, they’re at 801 W. 34th Street. Call them at (512) 371-9260.
More than Swine Flu to avoid this season
The Wall Street Journal has an article today that tells us H1N1 virus
dread is not the only thing to avoid this coming flu season.
Along with the new H1N1 swine-flu virus, officials are keeping a close eye on some nasty seasonal strains. One is widely resistant to oseltamivir, the popular antiviral drug marketed as tamiflu. And an emerging variant of another virus known for hitting the elderly hard isn’t fully covered by this year’s seasonal flu vaccine.
“This season is going to be crazier than ever,” said William Schaffner, an infectious-disease expert at Vanderbilt University.
I started my novel Viral Times in the first years of this decade. I imagined a time when multiple virus outbreaks would be like chasing terrorist groups. Too much of it is coming true. Now it looks like even if H1N1 won’t threaten seniors, the flu shots being sold now will leave them at risk. I recommend Viral Immunity by J.E. Williams if you want to take a proactive, natural medicine approach to staying healthy.
Viral Times 